[3H]Paroxetine binding and serotonin content of rat brain: absence of changes following antidepressant treatments
- 1 April 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 235 (1) , 137-142
- https://doi.org/10.1016/0014-2999(93)90833-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brainNeuropharmacology, 1992
- [3H]Paroxetine Binding and Serotonin Content of Rat Cortical Areas, Hippocampus, Neostriatum, Ventral Mesencephalic Tegmentum, and Midbrain Raphe Nuclei Region Following p-Chlorophenylalanine and p-Chloroamphetamine TreatmentJournal of Neurochemistry, 1992
- [3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei regionSynapse, 1991
- A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporterBiochemical Pharmacology, 1989
- Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3h]paroxetine binding to cerebral cortical membranes of the ratNeuropharmacology, 1987
- Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressantsEuropean Journal of Pharmacology, 1987
- Characterization of [3H]paroxetine binding to rat cortical membranesEuropean Journal of Pharmacology, 1985
- Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopramPsychopharmacology, 1984
- Receptor Sensitivity and the Mechanism of Action of Antidepressant TreatmentArchives of General Psychiatry, 1981
- Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipraminePsychopharmacology, 1980